XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 204,745 $ 188,657
Investment securities, available-for-sale 265,775 250,208
Accounts receivable, net 94,701 98,267
Interest and other receivables 5,378 4,083
Inventory 61,936 35,819
Prepaid expenses 42,761 39,091
Total current assets 675,296 616,125
Property and equipment, net 4,370 4,612
Operating lease right-of-use assets 54,280 51,855
Intangible assets, net 110,204 65,490
Restricted cash 5,770 5,770
Long-term inventory 4,707 4,628
Other assets 476 476
Total assets 855,103 748,956
Liabilities and stockholders’ equity    
Accounts payable 19,332 17,543
Accrued liabilities 311,265 236,711
Total current liabilities 330,597 254,254
Operating lease liabilities 49,189 47,800
Other long-term liabilities 11,273 15,147
Total liabilities 391,059 317,201
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized at March 31, 2024 and December 31, 2023; no shares issued and outstanding at March 31, 2024 andDecember 31, 2023 0 0
Common stock, $0.0001 par value; 225,000,000 shares authorized at March 31, 2024 and December 31, 2023; 164,959,736 shares and 164,650,219 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively 16 16
Additional paid-in capital 2,878,539 2,862,552
Accumulated deficit (2,414,282) (2,430,837)
Accumulated other comprehensive loss (229) 24
Total stockholders’ equity 464,044 431,755
Total liabilities and stockholders’ equity $ 855,103 $ 748,956